Doxa AB (publ) (DOXA.ST)
SEK 0.35
(-1.82%)
SEK 0.35
(-1.82%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | -100.0% |
| 2020 | 3.26 Million SEK | 18.88% |
| 2019 | 2.74 Million SEK | -10.88% |
| 2018 | 3.07 Million SEK | -6.76% |
| 2017 | 3.3 Million SEK | -20.07% |
| 2016 | 4.13 Million SEK | 2.58% |
| 2015 | 4.02 Million SEK | -10.43% |
| 2014 | 4.49 Million SEK | 26.09% |
| 2013 | 3.56 Million SEK | -17.52% |
| 2012 | 4.32 Million SEK | -0.83% |
| 2011 | 4.35 Million SEK | 283.29% |
| 2010 | 1.13 Million SEK | 159.0% |
| 2009 | 439 Thousand SEK | 314.15% |
| 2008 | 106 Thousand SEK | -68.55% |
| 2007 | 337 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | -23.7 Million SEK | 100.0% |
| 2024 Q1 | -16.7 Million SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2023 FY | - SEK | 0.0% |
| 2022 Q1 | -2.3 Million SEK | 42.5% |
| 2022 FY | - SEK | 0.0% |
| 2022 Q3 | - SEK | -200.0% |
| 2022 Q4 | - SEK | 100.0% |
| 2022 Q2 | - SEK | 100.0% |
| 2021 Q2 | 3.2 Million SEK | 6.67% |
| 2021 FY | - SEK | -100.0% |
| 2021 Q3 | 2.9 Million SEK | -9.38% |
| 2021 Q4 | -4 Million SEK | -237.93% |
| 2021 Q1 | 3 Million SEK | -8.0% |
| 2020 Q4 | 3.26 Million SEK | -1.18% |
| 2020 Q3 | 3.3 Million SEK | 3.13% |
| 2020 Q2 | 3.2 Million SEK | 10.34% |
| 2020 Q1 | 2.9 Million SEK | 5.72% |
| 2020 FY | 3.26 Million SEK | 18.88% |
| 2019 Q3 | 3.3 Million SEK | -10.81% |
| 2019 Q4 | 2.74 Million SEK | -16.88% |
| 2019 FY | 2.74 Million SEK | -10.88% |
| 2019 Q1 | 3.4 Million SEK | 10.46% |
| 2019 Q2 | 3.7 Million SEK | 8.82% |
| 2018 Q3 | 2.9 Million SEK | -9.38% |
| 2018 Q4 | 3.07 Million SEK | 6.14% |
| 2018 Q2 | 3.2 Million SEK | -8.57% |
| 2018 FY | 3.07 Million SEK | -6.76% |
| 2018 Q1 | 3.5 Million SEK | 6.03% |
| 2017 Q2 | 4.2 Million SEK | 0.0% |
| 2017 Q1 | 4.2 Million SEK | 1.69% |
| 2017 FY | 3.3 Million SEK | -20.07% |
| 2017 Q3 | 3.7 Million SEK | -11.9% |
| 2017 Q4 | 3.3 Million SEK | -10.78% |
| 2016 Q3 | 3.9 Million SEK | 0.0% |
| 2016 FY | 4.13 Million SEK | 2.58% |
| 2016 Q4 | 4.13 Million SEK | 5.9% |
| 2016 Q2 | 3.9 Million SEK | -7.14% |
| 2016 Q1 | 4.2 Million SEK | 4.32% |
| 2015 FY | 4.02 Million SEK | -10.43% |
| 2015 Q3 | 4.5 Million SEK | 25.0% |
| 2015 Q2 | 3.6 Million SEK | -7.69% |
| 2015 Q1 | 3.9 Million SEK | -13.24% |
| 2015 Q4 | 4.02 Million SEK | -10.53% |
| 2014 FY | 4.49 Million SEK | 26.09% |
| 2014 Q4 | 4.49 Million SEK | 4.53% |
| 2014 Q3 | 4.3 Million SEK | 16.22% |
| 2014 Q2 | 3.7 Million SEK | 12.12% |
| 2014 Q1 | 3.3 Million SEK | -7.43% |
| 2013 Q4 | 3.56 Million SEK | 8.16% |
| 2013 Q3 | 3.29 Million SEK | -8.14% |
| 2013 FY | 3.56 Million SEK | -17.52% |
| 2013 Q2 | 3.58 Million SEK | 0.0% |
| 2012 Q4 | 4.32 Million SEK | 0.0% |
| 2012 FY | 4.32 Million SEK | -0.83% |
| 2011 FY | 4.35 Million SEK | 283.29% |
| 2010 FY | 1.13 Million SEK | 159.0% |
| 2009 FY | 439 Thousand SEK | 314.15% |
| 2008 FY | 106 Thousand SEK | -68.55% |
| 2007 FY | 337 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 100.0% |
| Biotage AB (publ) | 437 Million SEK | 100.0% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | 100.0% |
| Elekta AB (publ) | 3.25 Billion SEK | 100.0% |
| iZafe Group AB (publ) | 4.05 Million SEK | 100.0% |
| Ortivus AB (publ) | 12.45 Million SEK | 100.0% |
| Ortivus AB (publ) | 12.45 Million SEK | 100.0% |
| Q-linea AB (publ) | 46.52 Million SEK | 100.0% |
| S2Medical AB (publ) | 4.09 Million SEK | 100.0% |
| Synsam AB (publ) | 707 Million SEK | 100.0% |